n-methylaspartate has been researched along with cl 316243 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akanuma, K; Ishii, K; Mori, A; Nakahara, T; Oikawa, F; Sakamoto, K; Ueda, K | 1 |
| Hanada, M; Ishii, K; Mori, A; Nakahara, T; Sakamoto, K | 1 |
2 other study(ies) available for n-methylaspartate and cl 316243
| Article | Year |
|---|---|
Protective effects of the β3-adrenoceptor agonist CL316243 against N-methyl-D-aspartate-induced retinal neurotoxicity.
Topics: Adrenergic beta-3 Receptor Agonists; Aminophenols; Animals; Dioxoles; Disease Models, Animal; Intravitreal Injections; Male; N-Methylaspartate; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retinal Diseases; Retinal Ganglion Cells; Sulfonamides; Time Factors | 2012 |
Impaired retinal vasodilator response to acetylcholine in a rat model of NMDA-induced retinal degeneration.
Topics: Acetylcholine; Adrenergic beta-3 Receptor Agonists; Animals; Dioxoles; Disease Models, Animal; Endothelial Cells; Male; N-Methylaspartate; Rats, Wistar; Receptors, Adrenergic, beta-3; Retinal Artery; Retinal Degeneration; Vasodilation | 2015 |